Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Retinoblastoma (RB), originating from the developing retina, is an aggressive intraocular malignant neoplasm in childhood. Biallelic loss of RB1 is conventionally considered a prerequisite for initiating RB development in most RB cases. Additional genetic mutations arising from genome instability following RB1 mutations are proposed to be required to promote RB development. Recent advancements in high throughput sequencing technologies allow a deeper and more comprehensive understanding of the etiology of RB that additional genetic alterations following RB1 biallelic loss are rare, yet epigenetic changes driven by RB1 loss emerge as a critical contributor promoting RB tumorigenesis. Multiple epigenetic regulators have been found to be dysregulated and to contribute to RB development, including noncoding RNAs, DNA methylations, RNA modifications, chromatin conformations, and histone modifications. A full understanding of the roles of genetic and epigenetic alterations in RB formation is crucial in facilitating the translation of these findings into effective treatment strategies for RB. In this review, we summarize current knowledge concerning genetic defects and epigenetic dysregulations in RB, aiming to help understand their links and roles in RB tumorigenesis. Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Citation

Linbin Zhou, Yan Tong, Bo Man Ho, Jiahui Li, Hoi Ying Emily Chan, Tian Zhang, Lin Du, Jing Na He, Li Jia Chen, Clement C Tham, Jason C Yam, Chi Pui Pang, Wai Kit Chu. Etiology including epigenetic defects of retinoblastoma. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024 May-Jun;13(3):100072

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38789041

View Full Text